| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | See Remarks
1 company
Townsend Adam J. is a Chief Commercial Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $74.05 | $370,250.00 | -6.2% | +16.4% | -27.4% | |
| Mar 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $63.84 | $319,200.00 | -6.2% | +34.4% | -1.7% | |
| Feb 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $55.85 | $279,250.00 | -6.9% | +54.0% | +14.2% | |
| Jan 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $50.70 | $253,500.00 | -10.4% | +52.5% | +19.3% | |
| Dec 5, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $50.38 | $251,900.00 | -10.4% | +30.2% | +31.3% | |
| Nov 3, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $58.54 | $292,700.00 | -10.4% | -8.4% | -22.0% | |
| Oct 3, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $66.69 | $333,450.00 | -10.4% | -17.6% | -36.2% | |
| Sep 6, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $60.38 | $301,900.00 | -10.4% | -14.9% | -26.3% | |
| Aug 15, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 12,500 | $69.00 | $862,500.00 | -22.6% | -31.7% | -52.3% | |
| Aug 11, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 12,500 | $67.00 | $837,500.00 | -22.6% | -32.8% | -50.5% |